146 related articles for article (PubMed ID: 37944197)
1. KIF22 promotes the proliferation and glycolysis of melanoma by activating EGFR/STAT3 signaling.
Zhong Z; Zhong H
Clinics (Sao Paulo); 2023; 78():100307. PubMed ID: 37944197
[TBL] [Abstract][Full Text] [Related]
2. KIF22 promotes bladder cancer progression by activating the expression of CDCA3.
Li K; Li S; Tang S; Zhang M; Ma Z; Wang Q; Chen F
Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34633053
[TBL] [Abstract][Full Text] [Related]
3. KIF22 coordinates CAR and EGFR dynamics to promote cancer cell proliferation.
Pike R; Ortiz-Zapater E; Lumicisi B; Santis G; Parsons M
Sci Signal; 2018 Jan; 11(515):. PubMed ID: 29382784
[TBL] [Abstract][Full Text] [Related]
4. KIF22 promotes multiple myeloma progression by regulating the CDC25C/CDK1/cyclinB1 pathway.
Zhai M; Miao J; Zhang R; Liu R; Li F; Shen Y; Wang T; Xu X; Gao G; Hu J; He A; Bai J
J Cancer Res Clin Oncol; 2024 May; 150(5):239. PubMed ID: 38713252
[TBL] [Abstract][Full Text] [Related]
5. KIF22 Promotes Development of Pancreatic Cancer by Regulating the MEK/ERK/P21 Signaling Axis.
Zhang R; Ma L; Wei Y; Wei K; Song T; Du Z; Feng Z
Biomed Res Int; 2022; 2022():6000925. PubMed ID: 35578724
[TBL] [Abstract][Full Text] [Related]
6. Effect of KIF22 on promoting proliferation and migration of gastric cancer cells via MAPK-ERK pathways.
Yu ZY; Jiang XY; Zhao RR; Qin JJ; Luo CJ; Ren YX; Ren W; Ma ZJ; Jiao ZY
Chin Med J (Engl); 2020 Apr; 133(8):919-928. PubMed ID: 32187050
[TBL] [Abstract][Full Text] [Related]
7. KIF2C promotes clear cell renal cell carcinoma progression via activating JAK2/STAT3 signaling pathway.
Deng H; Gong X; Ji G; Li C; Cheng S
Mol Cell Probes; 2023 Dec; 72():101938. PubMed ID: 37863123
[TBL] [Abstract][Full Text] [Related]
8. Suppression of KIF22 Inhibits Cell Proliferation and Xenograft Tumor Growth in Tongue Squamous Cell Carcinoma.
Liu Y; Li RH; Ren G; Jiang J
Biomed Res Int; 2020; 2020():6387545. PubMed ID: 32090103
[TBL] [Abstract][Full Text] [Related]
9. Forkhead Box q1 promotes invasion and metastasis in colorectal cancer by activating the epidermal growth factor receptor pathway.
Zhang JJ; Cao CX; Wan LL; Zhang W; Liu ZJ; Wang JL; Guo Q; Tang H
World J Gastroenterol; 2022 May; 28(17):1781-1797. PubMed ID: 35633908
[TBL] [Abstract][Full Text] [Related]
10. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
11. The tyrosine phosphorylated pro-survival form of Fas intensifies the EGF-induced signal in colorectal cancer cells through the nuclear EGFR/STAT3-mediated pathway.
Ta NL; Chakrabandhu K; Huault S; Hueber AO
Sci Rep; 2018 Aug; 8(1):12424. PubMed ID: 30127519
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of STAT3 signaling contributes to the anti-melanoma effects of chrysoeriol.
Liu YX; Chen YJ; Xu BW; Fu XQ; Ding WJ; Li SA; Wang XQ; Wu JY; Wu Y; Dou X; Liu B; Yu ZL
Phytomedicine; 2023 Jan; 109():154572. PubMed ID: 36610164
[TBL] [Abstract][Full Text] [Related]
13. STAT3 inhibitor BBI608 enhances the antitumor effect of gefitinib on EGFR-mutated non-small cell lung cancer cells.
Wang Q; Lu B; Zhang Y; Yu J; Guo J; Zhou Q; Lv H; Sun Y
Hum Cell; 2021 Nov; 34(6):1855-1865. PubMed ID: 34370268
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression.
Lo HW; Hsu SC; Xia W; Cao X; Shih JY; Wei Y; Abbruzzese JL; Hortobagyi GN; Hung MC
Cancer Res; 2007 Oct; 67(19):9066-76. PubMed ID: 17909010
[TBL] [Abstract][Full Text] [Related]
15. FABP4 Regulates Cell Proliferation, Stemness, Apoptosis, and Glycolysis in Colorectal Cancer via Modulating ROS/ERK/mTOR Pathway.
Gao Y; Wang Y; Wang X; Ma J; Wei M; Li N; Zhao Z
Discov Med; 2023 Jun; 35(176):361-371. PubMed ID: 37272103
[TBL] [Abstract][Full Text] [Related]
16. PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells.
Yao A; Xiang Y; Si YR; Fan LJ; Li JP; Li H; Guo W; He HX; Liang XJ; Tan Y; Bao LY; Liao XH
J Cell Biochem; 2019 Apr; 120(4):6542-6554. PubMed ID: 30368881
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor promotes proliferation and maintains multipotency of continuous cultured adipose stem cells via activating STAT signal pathway in vitro.
Ai G; Shao X; Meng M; Song L; Qiu J; Wu Y; Zhou J; Cheng J; Tong X
Medicine (Baltimore); 2017 Jul; 96(30):e7607. PubMed ID: 28746211
[TBL] [Abstract][Full Text] [Related]
18. PLOD1 promotes cell growth and aerobic glycolysis by regulating the SOX9/PI3K/Akt/mTOR signaling pathway in gastric cancer.
Zhang Y; Wu Y; Su X
Front Biosci (Landmark Ed); 2021 Aug; 26(8):322-334. PubMed ID: 34455762
[No Abstract] [Full Text] [Related]
19. Circular RNA ciRS-7 promotes the proliferation and metastasis of pancreatic cancer by regulating miR-7-mediated EGFR/STAT3 signaling pathway.
Liu L; Liu FB; Huang M; Xie K; Xie QS; Liu CH; Shen MJ; Huang Q
Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):580-586. PubMed ID: 30898507
[TBL] [Abstract][Full Text] [Related]
20. Suppression of EGFR/STAT3 activity by lupeol contributes to the induction of the apoptosis of human non‑small cell lung cancer cells.
Min TR; Park HJ; Ha KT; Chi GY; Choi YH; Park SH
Int J Oncol; 2019 Jul; 55(1):320-330. PubMed ID: 31115519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
